|2012 Annual Report
2013 Proxy Statement|
Auxilium is dedicated to keeping our investors informed about the latest corporate information. To this end, this section is designed to provide comprehensive, up-to-date, public information.
Auxilium Pharmaceuticals, Inc. at UBS Global Healthcare Conference (Replay)
May 21, 2013 at 3:00 p.m. ET
Auxilium Pharmaceuticals, Inc. at Bank of America Merrill Lynch Health Care Conference (Replay)
May 15, 2013 at 3:00 p.m. PT
|Auxilium Pharmaceuticals (NASDAQ: AUXL) was founded in 1999 to develop and market pharmaceutical products that focus on urology and sexual health. While we remain dedicated to this founding principle, Auxilium’s mission has expanded to include the development and marketing of novel treatment options for many of society’s unmet medical needs.
To support this mission of providing innovati... More >>
|There are currently no events scheduled.|
|There are currently no items available.|
Receive E-mail Alerts|
|To recieve email alerts about updates to Auxilium Pharmaceuticals, Inc. information, please enter your email address.|